title: The European Medicines Agency's strategies to meet the challenges of Alzheimer disease.
abstract: Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we highlight the strategies of the European Medicines Agency to help address such challenges.
authors.affiliation: 1] European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom. [2].
authors.forename: Manuel
authors.initials: M
authors.lastname: Haas
authors.affiliation: 1] Agenzia Italiana del Farmaco, Via del Tritone 181, 00187 Rome, Italy. [2].
authors.forename: Valentina
authors.initials: V
authors.lastname: Mantua
authors.affiliation: 1] Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3 53175 Bonn, Germany. [2].
authors.forename: Marion
authors.initials: M
authors.lastname: Haberkamp
authors.affiliation: Agenzia Italiana del Farmaco, Via del Tritone 181, 00187 Rome, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Pani
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Maria
authors.initials: M
authors.lastname: Isaac
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Florence
authors.initials: F
authors.lastname: Butlen-Ducuing
authors.affiliation: European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom.
authors.forename: Spiros
authors.initials: S
authors.lastname: Vamvakas
authors.affiliation: Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3 53175 Bonn, Germany.
authors.forename: Karl
authors.initials: K
authors.lastname: Broich
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D004345:Drug Industry; D005062:European Union; D006801:Humans; D007390:International Agencies
references.citation: Eur Neuropsychopharmacol. 2011 Nov;21(11):781-8
references.pmid: 21903360